Incannex Healthcare Limit... (IXHL)
Incannex Healthcare Statistics
Share Statistics
Incannex Healthcare has 27.55M shares outstanding. The number of shares has increased by 73.54% in one year.
Shares Outstanding | 27.55M |
Shares Change (YoY) | 73.54% |
Shares Change (QoQ) | 56.14% |
Owned by Institutions (%) | 0.07% |
Shares Floating | 21.5M |
Failed to Deliver (FTD) Shares | 7.89K |
FTD / Avg. Volume | 4.74% |
Short Selling Information
The latest short interest is 71.83K, so 0.26% of the outstanding shares have been sold short.
Short Interest | 71.83K |
Short % of Shares Out | 0.26% |
Short % of Float | 0.31% |
Short Ratio (days to cover) | 1.03 |
Valuation Ratios
The PE ratio is -2.58 and the forward PE ratio is -0.2. Incannex Healthcare's PEG ratio is 0.04.
PE Ratio | -2.58 |
Forward PE | -0.2 |
PS Ratio | 3973.73 |
Forward PS | 20.6 |
PB Ratio | 4.25 |
P/FCF Ratio | -2.96 |
PEG Ratio | 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Incannex Healthcare.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.88 |
Quick Ratio | 2.88 |
Debt / Equity | 0.03 |
Debt / EBITDA | -0.02 |
Debt / FCF | -0.02 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $1.33K |
Profits Per Employee | $-2.05M |
Employee Count | 9 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 30K |
Effective Tax Rate | -0.16% |
Stock Price Statistics
The stock price has increased by -74.79% in the last 52 weeks. The beta is 2.13, so Incannex Healthcare's price volatility has been higher than the market average.
Beta | 2.13 |
52-Week Price Change | -74.79% |
50-Day Moving Average | 1.05 |
200-Day Moving Average | 1.76 |
Relative Strength Index (RSI) | 39.63 |
Average Volume (20 Days) | 166.41K |
Income Statement
In the last 12 months, Incannex Healthcare had revenue of 12K and earned -18.46M in profits. Earnings per share was -1.14.
Revenue | 12K |
Gross Profit | 12K |
Operating Income | -30.04M |
Net Income | -18.46M |
EBITDA | -18.5M |
EBIT | -18.61M |
Earnings Per Share (EPS) | -1.14 |
Balance Sheet
The company has 5.86M in cash and 373K in debt, giving a net cash position of 5.49M.
Cash & Cash Equivalents | 5.86M |
Total Debt | 373K |
Net Cash | 5.49M |
Retained Earnings | -110.67M |
Total Assets | 11.11M |
Working Capital | 4.66M |
Cash Flow
In the last 12 months, operating cash flow was -15.85M and capital expenditures -277K, giving a free cash flow of -16.12M.
Operating Cash Flow | -15.85M |
Capital Expenditures | -277K |
Free Cash Flow | -16.12M |
FCF Per Share | -1 |
Margins
Gross margin is 100%, with operating and profit margins of -250341.67% and -153825%.
Gross Margin | 100% |
Operating Margin | -250341.67% |
Pretax Margin | -153575% |
Profit Margin | -153825% |
EBITDA Margin | -154200% |
EBIT Margin | -250341.67% |
FCF Margin | -134350% |
Dividends & Yields
IXHL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for IXHL.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 30, 2023. It was a backward split with a ratio of 1:4.
Last Split Date | Nov 30, 2023 |
Split Type | backward |
Split Ratio | 1:4 |
Scores
Altman Z-Score | -20.24 |
Piotroski F-Score | 2 |